1 Min Read
July 21 (Reuters) - Glaxosmithkline Plc:
* Submits EU filing for extended use of Relvar Ellipta in patients with controlled asthma on an ICS/LABA combination Further company coverage: (Bangalore.firstname.lastname@example.org)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.